Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 2 | +232K | 100% | $10.81 | +$2.5M |
Sells | 0 | ||||
Net | +2 | +232K | 100% | +$2.5M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Opaleye Management Inc. | 10%+ Owner | $38M | +$2.34M | +6.55% | Apr 25, 2024 |
Mark L. Baum | CHIEF EXECUTIVE OFFICER, Director | $24.8M | +$165K | +0.67% | Mar 22, 2024 |
Andrew R. Boll | Chief Financial Officer | $6.06M | Feb 20, 2024 | ||
John P. Saharek | CEO of ImprimisRx | $2.23M | Mar 1, 2024 | ||
Richard L. Md Lindstrom | Director | $1.02M | Sep 30, 2022 | ||
Martin A. Makary | Director | $365K | Jun 14, 2024 | ||
Teresa Sparks | Director | Jun 21, 2023 | |||
R. Lawrence Van Horn | Director | Jun 21, 2023 | |||
Robert Kammer | Director | Jun 25, 2021 | |||
Perry J. Sternberg | Director | Jun 14, 2024 | |||
Lauren P. Silvernail | Director | Jun 14, 2024 | |||
Adrienne L. Graves | Director | Jun 14, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|